Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02879162 |
|---|---|
| Brief Title: | Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours |
| First Submitted : | August 22, 2016 |
| First Submitted that Met QC Criteria : | August 22, 2016 |
| First Posted : | August 25, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | September 17, 2020 |
| Last Update Posted : | September 18, 2020 |